Corvus Pharmaceuticals rises 5%, prices $175M stock offering at $22.15
Source: SeekingAlpha
2026-01-22 01:10:22 ET
Read the full article on Seeking Alpha
For further details see:
Corvus Pharmaceuticals rises 5%, prices $175M stock offering at $22.15
Corvus Pharmaceuticals Inc.
NASDAQ: CRVS
CRVS Trading
4.39% G/L:
$16.63 Last:
647,446 Volume:
$15.90 Open:
CRVS Latest News
March 05, 2026 04:01:00 pm
Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
February 23, 2026 04:01:00 pm
Corvus Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
CRVS Stock Data
$1,643,805,638
59,046,523
N/A
41
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
